Literature DB >> 5584878

[Concerning the synthesis of lysolecithin and its ether analogs].

D Arnold, H U Weltzien, O Westphal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5584878     DOI： 10.1002/jlac.19677090126

Source DB:  PubMed          Journal:  Justus Liebigs Ann Chem        ISSN： 0075-4617


× No keyword cloud information.
  9 in total

1.  Ether lipids in oncology-welcoming address.

Authors:  O Westphal
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

2.  Antineoplastic activity of synthetic lysophospholipid analogs.

Authors:  W E Berdel
Journal:  Blut       Date:  1982-02

3.  Clinical phase I pilot study of the alkyl lysophospholipid derivative ET-18-OCH3.

Authors:  W E Berdel; U Fink; J Rastetter
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

4.  Phospholipid synthesis: Oxazaphospholanes and dioxaphospholanes as intermediates.

Authors:  H Eibl
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

5.  Response of acute myelomonocytic leukemia to alkyl-lysophospholipids. A case report.

Authors:  W E Berdel; U Fink; P A Maubach; B Permanetter; J Rastetter
Journal:  Blut       Date:  1982-03

Review 6.  Hexadecylphosphocholine: preclinical and the first clinical results of a new antitumor drug.

Authors:  C Unger; H Eibl
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Comparison of selective cytotoxicity of alkyl lysophospholipids.

Authors:  W R Vogler; A C Olson; S Okamoto; M Shoji; R L Raynor; J F Kuo; W E Berdel; H Eibl; J Hajdu; H Nomura
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

8.  An improved procedure for the synthesis of choline phospholipids via 2-bromoethyl dichlorophosphate.

Authors:  W J Hansen; R Murari; Y Wedmid; W J Baumann
Journal:  Lipids       Date:  1982-06       Impact factor: 1.880

Review 9.  The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer.

Authors:  Mark W Nachtigal; Alon D Altman; Rajat Arora; Frank Schweizer; Gilbert Arthur
Journal:  Cancers (Basel)       Date:  2022-07-07       Impact factor: 6.575
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.